-
公开(公告)号:US5693665A
公开(公告)日:1997-12-02
申请号:US584465
申请日:1996-01-10
申请人: Daniel Lesieur , Eric Fourmaintraux , Patrick Depreux , Philippe Delagrange , Pierre Renard , Beatrice Guardiola-Lemaitre
发明人: Daniel Lesieur , Eric Fourmaintraux , Patrick Depreux , Philippe Delagrange , Pierre Renard , Beatrice Guardiola-Lemaitre
IPC分类号: A61K31/165 , A61K31/17 , A61K31/18 , A61K31/34 , A61K31/343 , A61K31/40 , A61K31/403 , A61K31/404 , A61P3/00 , A61P3/04 , A61P9/00 , A61P9/08 , A61P9/10 , A61P25/20 , A61P25/24 , A61P25/26 , A61P43/00 , C07C231/02 , C07C233/02 , C07C233/05 , C07C233/08 , C07C233/09 , C07C233/58 , C07C273/02 , C07C275/24 , C07C275/26 , C07C303/38 , C07C311/03 , C07C311/10 , C07C311/11 , C07C327/38 , C07C335/12 , C07C335/14 , C07D209/14 , C07D307/81 , C07D333/58 , A61K31/38 , C07D335/06
CPC分类号: C07C233/08 , C07C233/05 , C07C233/58 , C07D307/81 , C07D333/58 , C07C2101/02 , C07C2101/04 , C07C2102/10
摘要: The invention relates to a compounds selected from these of formula (I): ##STR1## in which: R.sub.1, R.sub.2, R.sub.3 and A are as defined in the description, and a medicinal product containing the same useful for treating a melatoninergic disorder.
摘要翻译: 本发明涉及选自这些式(I)的化合物:其中:R 1,R 2,R 3和A如说明书中所定义,和含有可用于治疗褪黑激素的药物 紊乱。
-
公开(公告)号:US5780512A
公开(公告)日:1998-07-14
申请号:US826340
申请日:1997-03-26
申请人: Daniel Lesieur , Eric Fourmaintraux , Patrick Depreux , Philippe Delagrange , Pierre Renard , Beatrice Guardiola-Lemaitre
发明人: Daniel Lesieur , Eric Fourmaintraux , Patrick Depreux , Philippe Delagrange , Pierre Renard , Beatrice Guardiola-Lemaitre
IPC分类号: A61K31/165 , A61K31/17 , A61K31/18 , A61K31/34 , A61K31/343 , A61K31/40 , A61K31/403 , A61K31/404 , A61P3/00 , A61P3/04 , A61P9/00 , A61P9/08 , A61P9/10 , A61P25/20 , A61P25/24 , A61P25/26 , A61P43/00 , C07C231/02 , C07C233/02 , C07C233/05 , C07C233/08 , C07C233/09 , C07C233/58 , C07C273/02 , C07C275/24 , C07C275/26 , C07C303/38 , C07C311/03 , C07C311/10 , C07C311/11 , C07C327/38 , C07C335/12 , C07C335/14 , C07D209/14 , C07D307/81 , C07D333/58 , C07C233/04
CPC分类号: C07C233/08 , C07C233/05 , C07C233/58 , C07D307/81 , C07D333/58 , C07C2101/02 , C07C2101/04 , C07C2102/10
摘要: The invention relates to a compounds selected from these of formula (I): ##STR1## in which: R.sub.1, R.sub.2, R.sub.3 and A are as defined in the description, and a medicinal product containing the same useful for treating a melatoninergic disorder.
摘要翻译: 本发明涉及选自这些式(I)的化合物:其中:R 1,R 2,R 3和A如说明书中所定义,和含有可用于治疗褪黑激素的药物 紊乱。
-
3.Method of treating disorders of the melatoninergic system and a certain benzofuran containing compound 失效
标题翻译: 治疗褪黑激素系统疾病和某种含苯并呋喃的化合物的方法公开(公告)号:US5703121A
公开(公告)日:1997-12-30
申请号:US584466
申请日:1996-01-11
申请人: Daniel Lesieur , Eric Fourmaintraux , Patrick Depreux , Philippe Delagrange , Pierre Renard , Beatrice Guardiola-Lemaitre
发明人: Daniel Lesieur , Eric Fourmaintraux , Patrick Depreux , Philippe Delagrange , Pierre Renard , Beatrice Guardiola-Lemaitre
IPC分类号: A61K31/165 , A61K31/17 , A61K31/18 , A61K31/34 , A61K31/343 , A61K31/40 , A61K31/403 , A61K31/404 , A61P3/00 , A61P3/04 , A61P9/00 , A61P9/08 , A61P9/10 , A61P25/20 , A61P25/24 , A61P25/26 , A61P43/00 , C07C231/02 , C07C233/02 , C07C233/05 , C07C233/08 , C07C233/09 , C07C233/58 , C07C273/02 , C07C275/24 , C07C275/26 , C07C303/38 , C07C311/03 , C07C311/10 , C07C311/11 , C07C327/38 , C07C335/12 , C07C335/14 , C07D209/14 , C07D307/81 , C07D333/58
CPC分类号: C07C233/08 , C07C233/05 , C07C233/58 , C07D307/81 , C07D333/58 , C07C2101/02 , C07C2101/04 , C07C2102/10
摘要: The invention relates to a compound selected from those of formula (I): ##STR1## in which: R.sub.1, R.sub.2, R.sub.3 and A are as defined in the description, and Medicinal product containing the same useful for treating a disorder of the melatoninergic system.
摘要翻译: 本发明涉及选自式(I)的化合物:其中:R1,R2,R3和A如说明书中所定义,并且含有可用于治疗病症的药物的药物 褪黑激素系统。
-
公开(公告)号:US5721276A
公开(公告)日:1998-02-24
申请号:US657972
申请日:1996-05-30
申请人: Isabelle Lesieur , Patrick Depreux , Veronique Leclerc , Philippe Delagrange , Pierre Renard , Beatrice Guardiola Lemaitre
发明人: Isabelle Lesieur , Patrick Depreux , Veronique Leclerc , Philippe Delagrange , Pierre Renard , Beatrice Guardiola Lemaitre
IPC分类号: C07D333/60 , A61K31/165 , A61K31/34 , A61K31/343 , A61K31/35 , A61K31/352 , A61K31/38 , A61K31/381 , A61K31/403 , A61K31/404 , A61K31/405 , A61P3/04 , A61P9/08 , A61P9/10 , A61P25/00 , A61P25/20 , A61P25/24 , A61P25/26 , A61P43/00 , C07C231/02 , C07C235/34 , C07C235/36 , C07D209/18 , C07D307/79 , C07D307/80 , C07D307/92 , C07D311/92 , C07D333/24 , C07C233/05
CPC分类号: C07D307/79 , C07C235/34 , C07C235/36 , C07D209/18 , C07D307/92 , C07D311/92 , C07D333/24 , C07C2101/02 , C07C2101/04 , C07C2101/14
摘要: The invention relates to a compound selected from those of formula (I): ##STR1## in which A, B, X and R.sub.1 are as defined in the description, and medicinal product containing the same useful for treating a disorder of the melatoninergic system.
摘要翻译: 本发明涉及一种选自式(I)的化合物:其中A,B,X和R 1如说明书中所定义,其中含有相同用途的药物产品可用于治疗 褪黑激素系统。
-
公开(公告)号:US5420158A
公开(公告)日:1995-05-30
申请号:US035936
申请日:1993-03-23
申请人: Said Yous , Daniel Lesieur , Patrick Depreux , Beatrice Guardiola-Lemaitre , Gerard Adam , Pierre Renard , Daniel H. Caignard
发明人: Said Yous , Daniel Lesieur , Patrick Depreux , Beatrice Guardiola-Lemaitre , Gerard Adam , Pierre Renard , Daniel H. Caignard
IPC分类号: A61K31/135 , A61K31/16 , A61K31/215 , A61P17/00 , A61P25/00 , A61P37/00 , A61P43/00 , C07C233/05 , C07C233/58 , C07C233/60 , C07C233/63 , C07C275/24 , C07D295/10 , A01N1/00 , C07C229/34
CPC分类号: C07C233/63 , C07C233/05 , C07C233/58 , C07C233/60 , C07C275/24 , C07C2101/02 , C07C2101/04 , C07C2101/08 , C07C2101/14 , C07C2101/16
摘要: The invention relates to a compound selected from those of general formula (I): ##STR1## in which R, R.sub.1, R.sub.2 and R.sub.3 are as defined in the specification, an optical isomer, and an addition salt thereof with a pharmaceutically-acceptable base.Medicinal product which is useful in the treatment of disorders linked to abnormal melatonin activity.
摘要翻译: 本发明涉及选自通式(I)的化合物:其中R,R 1,R 2和R 3如本说明书中所定义的其中R 1,R 2和R 3如本文所定义的光学异构体及其加成盐与药学上 可接受的基地 可用于治疗与异常褪黑素活性相关的疾病的药用产品。
-
公开(公告)号:US5449689A
公开(公告)日:1995-09-12
申请号:US359879
申请日:1994-12-20
申请人: Daniel Lesieur , Said Yous , Patrick Depreux , Gerard Adam , Pierre Renard , Bruno Pfeiffer , Beatrice Guardiola-Lemaitre
发明人: Daniel Lesieur , Said Yous , Patrick Depreux , Gerard Adam , Pierre Renard , Bruno Pfeiffer , Beatrice Guardiola-Lemaitre
IPC分类号: A61K31/17 , A61K8/42 , A61K8/46 , A61P1/00 , A61P17/00 , A61P25/00 , A61P25/18 , A61P25/20 , A61P25/24 , A61P25/26 , A61P25/28 , A61P35/00 , A61Q7/00 , A61Q17/00 , A61Q19/00 , C07C273/02 , C07C275/24 , C07C335/12 , C07C335/14
CPC分类号: C07C335/12 , A61K8/42 , A61K8/46 , A61Q19/00 , C07C275/24 , A61Q17/00 , A61Q7/00 , C07C2101/02 , C07C2101/14 , Y10S514/923
摘要: A compound selected from those of formula (I): ##STR1## in which the meanings of R, R.sub.1, R.sub.2 and X are as defined in the specification, andmedicinal products containing the same which are useful in treating or in preventing a disorder of the melatoninergic system.
摘要翻译: 选自式(I)的化合物:其中R,R 1,R 2和X的含义如说明书中所定义的式(I)和含有该化合物的药物,其可用于治疗或预防 褪黑激素系统紊乱。
-
公开(公告)号:US5385944A
公开(公告)日:1995-01-31
申请号:US53911
申请日:1993-04-27
申请人: Daniel Lesieur , Said Yous , Patrick Depreux , Gerard Adam , Pierre Renard , Bruno Pfeiffer , Beatrice Guardiola-Lemaitre
发明人: Daniel Lesieur , Said Yous , Patrick Depreux , Gerard Adam , Pierre Renard , Bruno Pfeiffer , Beatrice Guardiola-Lemaitre
IPC分类号: A61K31/17 , A61K8/42 , A61K8/46 , A61P1/00 , A61P17/00 , A61P25/00 , A61P25/18 , A61P25/20 , A61P25/24 , A61P25/26 , A61P25/28 , A61P35/00 , A61Q7/00 , A61Q17/00 , A61Q19/00 , C07C273/02 , C07C275/24 , C07C335/12 , C07C335/14 , C07C335/06
CPC分类号: C07C335/12 , A61K8/42 , A61K8/46 , A61Q19/00 , C07C275/24 , A61Q17/00 , A61Q7/00 , C07C2101/02 , C07C2101/14 , Y10S514/923
摘要: A compound selected from those of formula (I): ##STR1## in which the meanings of R, R.sub.1, R.sub.2 and X are defined in the specification, andmedicinal products containing the same which are useful in treating or in preventing a disorder of the melatoninergic system.
摘要翻译: 选自式(I)的化合物:其中R,R 1,R 2和X的含义在本说明书中定义的式(I)和含有该化合物的药物,其可用于治疗或预防 褪黑激素系统紊乱。
-
8.(Aryl(alkyl)carbonyl)-heterocyclic compounds, compositions and use 失效
标题翻译: (芳基(烷基)羰基) - 杂环化合物,组合物和用途公开(公告)号:US5387586A
公开(公告)日:1995-02-07
申请号:US206451
申请日:1994-03-04
申请人: Ousmane Diouf , Daniel Lesieur , Patrick Depreux , Beatrice Guardiola-Lemaitre , Daniel-Henri Caignard , Pierre Renard , Gerard Adam
发明人: Ousmane Diouf , Daniel Lesieur , Patrick Depreux , Beatrice Guardiola-Lemaitre , Daniel-Henri Caignard , Pierre Renard , Gerard Adam
IPC分类号: A61K31/42 , A61K31/423 , A61K31/425 , A61K31/428 , A61K31/445 , A61K31/54 , A61P25/00 , A61P25/18 , A61P25/20 , A61P25/24 , A61P25/26 , A61P43/00 , C07D263/58 , C07D277/68 , C07D413/06 , C07D417/06 , A61K31/535 , C07D417/14
CPC分类号: C07D263/58 , C07D277/68 , C07D413/06 , C07D417/06
摘要: The invention relates to a compound selected from those of formula (I): ##STR1## wherein Ar, n, B and A are as defined in the description, to their optical isomers, and to their addition salts there of with a pharmaceutically-acceptable acid or base.Medicinal product which is useful for treating pain and treating or preventing pathologies which require psychotropic agents.
摘要翻译: 本发明涉及从式(I)的化合物中选择的化合物:其中Ar,n,B和A如说明书中所定义,与它们的光学异构体及其与 药学上可接受的酸或碱。 可用于治疗疼痛和治疗或预防需要精神药物的病理学的药用产品。
-
9.(Aryl(alkyl)carbonyl)-heterocyclic compounds and their use in the treatment of anxiety and depression 失效
标题翻译: (芳基(烷基)羰基) - 杂环化合物及其在治疗焦虑和抑郁中的应用公开(公告)号:US5534517A
公开(公告)日:1996-07-09
申请号:US296665
申请日:1994-08-26
申请人: Ousmane Diouf , Daniel Lesieur , Patrick Depreux , Beatrice Guardiola-Lemaitre , Daniel-Henri Caignard , Pierre Renard , Gerard Adam
发明人: Ousmane Diouf , Daniel Lesieur , Patrick Depreux , Beatrice Guardiola-Lemaitre , Daniel-Henri Caignard , Pierre Renard , Gerard Adam
IPC分类号: A61K31/42 , A61K31/423 , A61K31/425 , A61K31/428 , A61K31/445 , A61K31/54 , A61P25/00 , A61P25/18 , A61P25/20 , A61P25/24 , A61P25/26 , A61P43/00 , C07D263/58 , C07D277/68 , C07D413/06 , C07D417/06 , A61K31/495 , A61K31/535
CPC分类号: C07D263/58 , C07D277/68 , C07D413/06 , C07D417/06
摘要: The invention relates to a compound selected from those of formula (I): ##STR1## wherein Ar, n, B and A are as defined in the description, to their optical isomers, and to their addition salts there of with a pharmaceutically-acceptable acid or base. The compounds are useful for treating or preventing anxiety and depression.
摘要翻译: 本发明涉及从式(I)的化合物中选择的化合物:其中Ar,n,B和A如说明书中所定义,与它们的光学异构体及其与 药学上可接受的酸或碱。 该化合物可用于治疗或预防焦虑和抑郁。
-
公开(公告)号:US5389683A
公开(公告)日:1995-02-14
申请号:US930285
申请日:1992-08-14
申请人: Daniel Lesieur , Said Yous , Patrick Depreux , Gerard Adam , Pierre Renard , Bruno Pfeiffer , Beatrice Guardiola-Lemaitre
发明人: Daniel Lesieur , Said Yous , Patrick Depreux , Gerard Adam , Pierre Renard , Bruno Pfeiffer , Beatrice Guardiola-Lemaitre
IPC分类号: A61K31/17 , A61K8/42 , A61K8/46 , A61P1/00 , A61P17/00 , A61P25/00 , A61P25/18 , A61P25/20 , A61P25/24 , A61P25/26 , A61P25/28 , A61P35/00 , A61Q7/00 , A61Q17/00 , A61Q19/00 , C07C273/02 , C07C275/24 , C07C335/12 , C07C335/14 , C07C275/06
CPC分类号: C07C335/12 , A61K8/42 , A61K8/46 , A61Q19/00 , C07C275/24 , A61Q17/00 , A61Q7/00 , C07C2101/02 , C07C2101/14 , Y10S514/923
摘要: A compound selected from those of formula (I): ##STR1## in which the meanings of R, R.sub.1, R.sub.2 and X are as defined in the specification, andmedicinal products containing the same which are in treating or in preventing a disorder of the melatoninergic system.
摘要翻译: 选自式(I)的化合物:其中R,R 1,R 2和X的含义如说明书中所定义的其中的化合物和含有该化合物的药物,其用于治疗或预防 褪黑激素系统紊乱。
-
-
-
-
-
-
-
-
-